Atlas Trials

Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

Clinical trial NCT07252726 · RECRUITING

Trial details

NCT number
NCT07252726
Sponsor
Ottawa Hospital Research Institute
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Metastatic Breast CancerMetastatic Prostate Cancer
Start date
2026-02-02
Primary completion
2027-03-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.